U.S. Pharmaceutical Isolators Market Trends Report, 2022-2030
The U.S. Pharmaceutical Isolators market size was valued at US$ 150.4 Million in 2021 and is expected to hit US$ 235.2 Million by 2030, growing at a compound annual growth rate (CAGR) of 6.9% from 2022 to 2030.
Key Takeaways:
· The closed isolators segment is expected to witness a CAGR of 6.5% from 2022 to 2030 owing to the ability to operate without personnel access to the critical zone, making them suitable for application in the preparation of toxic materials
· The positive pressure segment accounted for 54.9% of the overall revenue share in 2020, owing to its demand in sterile processes when the process is of particular significance and keeping any contaminants out of the isolator is a priority
· Companies are collaborating with educational institutions along with their in-house R&D facilities for developing processes and technologies that offer a sustainable advantage in the future
· In February 2021, Comecer S.p.A partnered with Illuminate Manufacturing Intelligence, to integrate Illuminate, a pharmaceutical production solution based on industry 4.0, to get real-time updates of their manufacturing equipment
Growth Factors:
The growth is expected to be driven by the rapid growth of the pharmaceutical industry coupled with advancements in technologies used in the pharmaceutical industry.
The COVID-19 pandemic has boosted the demand for drug manufacturing and has increased the demand for aseptic process manufacturing. Furthermore, the increasing requirement for equipment that allows the containment of pharmaceutical processes has brought isolators to the forefront. The demand for pharmaceutical isolators on a small scale and the possibility of faster lead times have given a new boost to market growth.
The COVID-19 pandemic has boosted demand for smaller batch processing systems that helps save costs and reduce batch contamination. Furthermore, the U.S. is focusing on domestic competitiveness and has prioritized ‘reshoring’ of pharmaceutical manufacturing to reduce dependence on China which is expected to boost the market growth in the country.
Pharmaceutical isolators are used extensively in pharmaceutical manufacturing facilities since they provide tight enclosures, which maintain aseptic conditions and ensure worker safety. It eliminates the changing areas required in cleanrooms, aids in keeping the operating costs low and eliminates the need for personal protective equipment.
Fill-finish manufacturing of prefilled syringes and development of new drugs, generic medicines, and biosimilars, coupled with stringent government regulations related to controlling the quality of medicines and ensuring the deployment of good manufacturing practices are factors expected to augment the demand for pharmaceutical isolators in the U.S.
Rapid developments in the pharmaceuticals and healthcare industries have led to the increased development of modern therapies. Continuous progress in gene therapies has improved the demand for batch development of treatment methods for a small and specific population thereby boosting the demand for pharmaceutical isolators in the U.S.
Report Scope of the U.S. Pharmaceutical Isolators Market
|
Report Coverage |
Details |
|
Market Size in 2021 |
USD 150.4 Million |
|
Revenue Projection By 2030 |
USD 235.2 Million |
|
Growth Rate |
CAGR of 6.9% from 2022 to 2030 |
|
Base Year |
2021 |
|
Historical data |
2017 - 2020 |
|
Forecast Period |
2022 to 2030 |
|
Segments Covered |
Type, pressure |
|
Companies Mentioned |
COMECER S.p.A.; LAF Technologies; Iso Tech Design; Nuaire; Getinge AB; SKAN AG; M. BRAUN INERTGAS-SYSTEME GMBH; AZBIL TELSTAR, S.L.U.; Syntegon Technologies GmbH; IMA SpA |
Type Insights
The open pharmaceutical isolator led the market and accounted for the largest revenue share of 62.5% in 2021. Open isolators are different from closed isolators as they are designed for continuous or semi-continuous egress and/or ingress of materials during operation through one or more openings while maintaining a protective internal environment.
Open isolators have openings to the surrounding environment that are cautiously engineered to separate the inner isolator environment from the surrounding room. The equipment is utilized for the aseptic filling of pharmaceutical products. For maintenance operations on this isolator type, products do not necessarily have to be sterile.
The demand for closed isolators is projected to witness a CAGR of 6.5% over the forecast period. The equipment can operate without personnel access to the critical zone, making them capable of levels of separation between the external and internal environment unattainable with other technologies.
Closed isolator systems eliminate external contamination from the system’s interior by undertaking material transfer through auxiliary equipment to aseptic connection, rather than the usage of openings to the surrounding environment. Closed systems are sealed throughout operations.
Pressure Insights
The positive pressure segment led the U.S. pharmaceutical isolators market and accounted for the largest revenue share of 54.9% in 2021. Positive pressure isolators protect the process while negative pressure isolators protect the person. In positive pressure, the pressure inside the containment system is larger than that outside.
Positive pressure systems are utilized in the pharmaceutical industry to maintain process integrity. In the pharmaceutical industry, these systems are utilized in sterile processes when the process is of particular significance, and keeping any contaminants or germs out of the isolator is a priority.
The negative pressure segment is projected to witness a CAGR of 6.4% over the forecast period. Negative pressure pharmaceutical isolators are utilized to protect the environment and the operator from a wide range of active ingredients, volatile drugs, and hazardous molecules.
In negative pressure isolators, the air pressure outside is higher than the pressure inside the isolator. This is accomplished by running the inlet air at 10-30% lower than the supply air. Negative pressure is sustained from -30 to -20 Pa so that it stops particles from evading the isolator.
Key Companies & Market Share Insights
The competitive environment in the market is driven by innovations in technology for the use of isolators. Companies operating in the market are investing heavily in R&D as well as developing instruments to optimize production and improve the efficiency of bio-decontamination systems.
Manufacturers in the market have been focusing on technological advancements and integrating Artificial Intelligence (AI) and Industry 4.0 into their product offerings. In addition, increasing collaborations with contract manufacturers are expected to result in high competitive rivalry over the coming years. Some of the prominent players in the U.S. pharmaceutical isolators market include:
Segments Covered in the Report
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects. Further, this research study investigates market size, production, consumption and its development trends at U.S. for the period of 2017 to 2030
Key Points Covered in U.S. Pharmaceutical Isolators Market Study:
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers